Document Type

Student Research Paper

Date

Summer 2022

Academic Department

Chemistry and Biochemistry

Faculty Advisor(s)

Dr. Jeffrey Rood and Dr. Jane Cavender

Abstract

Developing drugs to combat disease is costly and time-consuming. Efficient methods for rapid drug screening for diseases such as Type 2 diabetes mellitus or cancer would be extremely advantageous. Diabetes effects 33.3 million people in the United States and 462 million worldwide and 17 million new cases of cancer are diagnosed each year. Many diseases result from the cells inability to respond to external signals that bind to receptors on the cytoplasmic membrane. This research attempted to create a cell line containing an intracellular protein fused to GFP. This protein would alter its cellular location and serve as an indicator that the cytoplasmic membrane receptor was activated or inactivated. Using Lipofectamine 3000, a plasmid encoding fusion protein was transfected into mouse cells, followed by 2 weeks of selection with gentamicin. The highest intensity-expressing cells were selected by using FACS. Studies are on-going to confirm the fusion proteins response to external signals.

Notes

Scholarship, Creative Arts, and Research Project (SCARP)

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.